Suppr超能文献

[一例难以与原发性胰腺癌相鉴别的结直肠癌胰腺转移病例]

[A Case of Metastasis to the Pancreas from Colorectal Cancer Which Was Difficult to Distinguish from Primary Pancreatic Cancer].

作者信息

Hirano Masataka, Komatsu Hisateru, Aomatsu Michihiro, Tsuji Yoshito, Takeuchi Takuro, Yokono Yoshinori, Nishizawa Yujiro, Inoue Akira, Kagawa Yoshinori, Miyazaki Yasuhiro, Tomokuni Akira, Fushimi Hiroaki, Motoori Masaaki, Fujitani Kazumasa, Iwase Kazuhiro

机构信息

Dept. of Gastroenterological Surgery, Osaka General Medical Center.

出版信息

Gan To Kagaku Ryoho. 2021 Dec;48(13):1789-1791.

Abstract

A man in his 50s underwent laparoscopic sigmoid colectomy for sigmoid colon cancer with liver metastasis(cT4aN1M1a, cStage Ⅳa), followed by partial liver resection(S4, S6). One and a half years after the initial surgery, CEA and CA19-9 increased, and contrast-enhanced CT and MRI showed a hypovascular lesion with dilation of the distal pancreatic duct in the pancreatic body. Adenocarcinoma was detected by brushing cytology of the lesion and pancreatic juice cytology by ERCP. From the results of various examinations, the lesion was diagnosed as pancreatic ductal adenocarcinoma. We performed distal pancreatectomy, and initially the histopathological diagnosis was pancreatic body cancer(pT3N1aM0, pStage ⅡB). In a follow-up CT after surgery, a suspected metastatic lymph node was pointed out in the mediastinum, but it was difficult to distinguish between metastasis from colorectal cancer and one from pancreatic cancer. Immunostaining of the tumor tissue and comparative study of the excised specimens of colon and pancreas was performed in order to assume the primary lesion of the lymph node. As a result, both tissues were CK7(-)/CK20(+), and the lesion at first considered to be primary pancreatic cancer was originally the pancreatic metastasis from colon cancer. Bone metastases were also found on FDG-PET/CT around the same time, and then systemic chemotherapy for colorectal cancer was introduced. Four and a half years have passed since the first surgery, and he is still alive and undergoing treatment.

摘要

一名50多岁的男性因乙状结肠癌伴肝转移(cT4aN1M1a,c期Ⅳa)接受了腹腔镜乙状结肠切除术,随后进行了部分肝切除术(S4、S6)。初次手术后一年半,癌胚抗原(CEA)和糖类抗原19-9(CA19-9)升高,增强CT和磁共振成像(MRI)显示胰体部有一个低血运病变,伴有远端胰管扩张。通过病变部位的刷检细胞学检查和经内镜逆行胰胆管造影(ERCP)的胰液细胞学检查发现了腺癌。根据各项检查结果,该病变被诊断为胰腺导管腺癌。我们进行了胰体尾切除术,最初的组织病理学诊断为胰体癌(pT3N1aM0,p期ⅡB)。术后的随访CT中,纵隔发现一个可疑转移淋巴结,但难以区分是结直肠癌转移还是胰腺癌转移。为了推测该淋巴结的原发灶,对肿瘤组织进行了免疫染色,并对结肠和胰腺的切除标本进行了对比研究。结果显示,两种组织均为细胞角蛋白7(CK7)(-)/细胞角蛋白20(CK20)(+),最初被认为是原发性胰腺癌的病变原本是结肠癌的胰腺转移。大约在同一时间,氟代脱氧葡萄糖正电子发射断层显像/X线计算机体层成像(FDG-PET/CT)上也发现了骨转移,随后开始了针对结直肠癌的全身化疗。自首次手术以来已过去四年半,他仍然健在并正在接受治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验